Small cell lung cancer responds to immunogenic chemotherapy followed by PD-1 blockade
Sequential combination of immunogenic cell death (ICD)-induced interventions with subsequent immunotherapy has shown efficacy in preclinical models and clinical evaluation. Recently, a clinical trial enrolling small cell lung cancer patients treated with amrubicin together with PD-1 blockade confirm...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Taylor & Francis Group
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/c51fb2797cc54bd2a0fe9b6c95667874 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|